Nitrates in combination with hydralazine in cardiorenal syndrome: a randomized controlled proof‐of‐concept study

AIMS: Cardiorenal syndrome (CRS) is a common problem of great morbidity and mortality. Hydralazine–isosorbide dinitrate (H‐ISDN) may be used in renal failure and may improve exercise capacity in heart failure (HF). Our proof‐of‐concept study aimed to evaluate early evidence of efficacy, safety, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Shir Lynn, Gandhi, Mihir, Woo, Kai Lee, Chua, Horng Ruey, Lim, Yoke Ching, Sim, David K.L., Lee, Sheldon S.G., Teoh, Yee Leong, Richards, Arthur Mark, Lam, Carolyn S.P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754984/
https://www.ncbi.nlm.nih.gov/pubmed/33150715
http://dx.doi.org/10.1002/ehf2.13076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754984/
https://www.ncbi.nlm.nih.gov/pubmed/33150715
http://dx.doi.org/10.1002/ehf2.13076

Ejemplares similares